ddPCR

Global PCR and Realtime PCR Testing Market Forecast to Decline at a CAGR of -10.93% from 2020 to reach $12,546.83 Million in 2025 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 22, 2021

The global polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market reached a value of nearly $22,380 million in 2020, having increasing at a compound annual growth rate (CAGR) of 28.11% since 2015.

Key Points: 
  • The global polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market reached a value of nearly $22,380 million in 2020, having increasing at a compound annual growth rate (CAGR) of 28.11% since 2015.
  • The global polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market is expected to stabilize and reach $17,054.69 million in 2030, at a CAGR of 6.33%.
  • North America was the largest region in the global polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market, accounting for 34.5% of the total in 2020.
  • The polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market size will decline the least in Indonesia at $85.8 million.

$508.8 Million Digital PCR Global Market to 2028 - Opportunity Analysis and Industry Forecasts - ResearchAndMarkets.com

Retrieved on: 
Monday, June 21, 2021

The "Digital PCR Market by Technologies, Product Type, Application and End User: Global Opportunity Analysis and Industry Forecast, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Digital PCR Market by Technologies, Product Type, Application and End User: Global Opportunity Analysis and Industry Forecast, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global digital polymerase chain reaction market generated $508.8 million in 2020 and is projected to reach $1,139.9 million by 2028, growing at a CAGR of 9.1% from 2021 to 2028.
  • By technology, the market is bifurcated into droplet digital PCR (ddPCR), chip based digital PCR and BEAMing digital PCR.
  • This report entails a detailed quantitative analysis of the current market trends from 2020 to 2028 to identify prevailing opportunities along with a strategic assessment of the global digital PCR market.

Global Digital PCR Market (2020 to 2027) - by Treatment Type, Product Type, Application, and End-user

Retrieved on: 
Wednesday, February 3, 2021

The global digital polymerase chain reaction market is segmented into technology, type, application, end user, and region.

Key Points: 
  • The global digital polymerase chain reaction market is segmented into technology, type, application, end user, and region.
  • By technology, the market is categorized into droplet digital PCR (ddPCR) and BEAMing digital PCR.
  • Product launch and acquisition was the most common strategies adopted among key players to expand their product offerings and strengthen their foothold in the global market.
  • This report highlights the market dynamics to understand the global digital polymerase chain reaction market and capitalize on the prevailing opportunities.

Outlook on the Digital PCR Global Market to 2027 - Opportunity Analysis and Industry Forecast - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 3, 2021

The "Digital PCR Market by Treatment Type, Product Type, Application, and End User: Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Digital PCR Market by Treatment Type, Product Type, Application, and End User: Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global digital polymerase chain reaction market generated $398 million in 2019, and is projected to reach $1,052 million by 2027, growing at a CAGR of 12.3% from 2020 to 2027.
  • By technology, the market is categorized into droplet digital PCR (ddPCR) and BEAMing digital PCR.
  • This report highlights the market dynamics to understand the global digital polymerase chain reaction market and capitalize on the prevailing opportunities.

Applications of Digital PCR in Clinical Research, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, November 19, 2020

This webinar will describe the intrinsic potential of droplet digital (ddPCR) in clinical research for three different applications:

Key Points: 
  • This webinar will describe the intrinsic potential of droplet digital (ddPCR) in clinical research for three different applications:
    During the talk, the featured speaker will analyze the rationale for dPCR selection and present relevant case studies.
  • Join Jan Hellemans, PhD, Co-founder and Chief Technology Officer, Biogazelle , in a live webinar on Tuesday, November 24, 2020 at 10am EST (3pm GMT/UK).
  • For more information, or to register for this event, visit Applications of Digital PCR in Clinical Research.
  • Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community.

Polymerase Chain Reaction (PCR) and Real-Time PCR Testing Market Worth $22.4 Billion in 2020, due to the Surge in Number of Tests Being Conducted for the Diagnosis of COVID-19

Retrieved on: 
Wednesday, May 6, 2020

DUBLIN, May 6, 2020 /PRNewswire/ -- The "Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) Testing Global Market Report 2020-30: Covid 19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, May 6, 2020 /PRNewswire/ -- The "Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) Testing Global Market Report 2020-30: Covid 19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering.
  • The global polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market is expected to grow from $7.5 billion in 2019 to about $22.4 billion in 2020 as there is a surge in the number of tests being conducted for the diagnosis of Covid-19.
  • North America was the largest region in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market in 2019.
  • It places the market within the context of the wider polymerase chain reaction and real-time polymerase chain reaction testing market, and compares it with other markets.

Polymerase Chain Reaction (PCR) and Real-Time PCR Testing Markets, 2020-2030: COVID-19 Implications and Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 5, 2020

The "Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) Testing Global Market Report 2020-30: Covid 19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) Testing Global Market Report 2020-30: Covid 19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering.
  • It places the market within the context of the wider polymerase chain reaction and real-time polymerase chain reaction testing market, and compares it with other markets.
  • The global polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market is expected to grow from $7.5 billion in 2019 to about $22.4 billion in 2020 as there is a surge in the number of tests being conducted for the diagnosis of Covid-19.
  • North America was the largest region in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market in 2019.

Bio-Rad Receives FDA Emergency Use Authorization for Droplet Digital PCR SARS-CoV-2 Test Kit

Retrieved on: 
Tuesday, May 5, 2020

Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its SARS-CoV-2 Droplet Digital PCR (ddPCR) test kit has been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA).

Key Points: 
  • Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its SARS-CoV-2 Droplet Digital PCR (ddPCR) test kit has been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA).
  • The SARS-CoV-2 Droplet Digital PCR (ddPCR) test runs on Bio-Rads QX200 and QXDx ddPCR systems.
  • Bio-Rads single-well SARS-CoV-2 ddPCR test provides clinicians with a high degree of sensitivity that can significantly improve the accuracy of reported results.
  • The SARS-CoV-2 ddPCR Test Kit has been authorized for emergency use by FDA under an EUA as described in this document.

New Studies Find Bio-Rad’s QX200 Droplet Digital PCR System Can Detect COVID-19 With Greater Sensitivity and Precision Than Other Existing Molecular Tests

Retrieved on: 
Thursday, March 19, 2020

The second study2, led by the National Institute of Metrology and provincial CDCs in China, also concluded that Droplet Digital PCR significantly improves diagnostic detection accuracy of SARS-CoV-2 from 28.2% to 87.4%, thereby reducing false negatives.

Key Points: 
  • The second study2, led by the National Institute of Metrology and provincial CDCs in China, also concluded that Droplet Digital PCR significantly improves diagnostic detection accuracy of SARS-CoV-2 from 28.2% to 87.4%, thereby reducing false negatives.
  • Furthermore, they found that Droplet Digital PCR is more sensitive and suitable for low virus load specimens from patients under isolation and observation even without any clinical symptoms.
  • MedRxiv reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
  • BIO-RAD, DROPLET DIGITAL PCR, and ddPCR, are trademarks of Bio-Rad Laboratories, Inc. in certain jurisdictions.

Global Digital PCR (dPCR) Market 2020-2024 | Evolving Opportunities with Bio-Rad Laboratories Inc. and Expedeon AG | Technavio

Retrieved on: 
Thursday, February 20, 2020

In addition, the growing applications of BEAMing technology-based dPCR workflows is anticipated to boost the growth of the digital PCR (dPCR) market.

Key Points: 
  • In addition, the growing applications of BEAMing technology-based dPCR workflows is anticipated to boost the growth of the digital PCR (dPCR) market.
  • Major Five Digital PCR (dPCR) Market Companies:
    Bio-Rad Laboratories Inc. is headquartered in the US and operates the business under various segments such as Life Science and Clinical Diagnostics.
  • The company offers QX200 AutoDG Droplet Digital PCR System, QX200 Droplet Digital PCR System, ddPCR Supermixes, ddPCR Assays, ddPCR Kits, ddPCR Oils, ddPCR Consumables, and PX1 Plate Sealer.
  • Expedeon AG is headquartered in Germany and offers TruePrime, CovCheck PCR Kits, and SunScript Reverse Transcriptase Kits.